GlaxoSmithKline's new CEO prepares to trim drug pipeline

LONDON, July 21 (Reuters) - GlaxoSmithKline's new chief executive, who has already made her mark with plans to divest some nutritional products, will turn next week to the main business of focusing the company's pipeline of new drugs.